Philips Respironics Showcases Innovations to Help Improve the Quality of Life
for Better Sleep and Breathing at ERS 2013
BARCELONA, Spain, September 7, 2013
BARCELONA, Spain, September 7, 2013 /PRNewswire/ --
Today at ERS 2013, the European Respiratory Society (ERS) Annual Congress in
Barcelona, Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX:
PHIA), is showcasing patient-centered innovations that represent the future of
health care for patients with chronic respiratory diseases. Dedicated to
serving as an ally to clinicians in improving the lives of individuals
suffering from sleep and respiratory issues, Philips Respironics is
demonstrating integrated programs and science-based solutions through 11
September at ERS.
(Photo: http://photos.prnewswire.com/prnh/20130907/638219-a )
(Photo: http://photos.prnewswire.com/prnh/20130907/638219-b )
Respiratory diseases, such as COPD and sleep-disordered breathing, are the
second leading cause of mortality in Europe, costing an estimated €102 billion
annually. This year at ERS, Philips Respironics offers providers a holistic
suite of solutions, ranging from the brand new Wisp minimal contact nasal mask
for sleep-disordered breathing and chronic respiratory conditions, to the
CoughAssist E70 for patients with ineffective cough.
"Philips is committed to making a difference in the management of sleep and
respiratory diseases," said Yann Goïot, Market Group Leader for Europe, Middle
East, and Africa. "Our goal is to help clinicans establish healthier patients,
healthier practices and, in turn, healthier businesses."
Wisp patient interface and enhanced solutions for sleep-disordered breathing
and chronic respiratory insufficiency diseases
Comfort, ease-of-fit and performance are critical to patient adherence.
Philips Respironics will complement its mask portfolio with the introduction
of the soon-to-be-available Wisp minimal contact nasal mask, an interface
which has a unique tip-of-the-nose cushion that sits below the nasal bridge
for a minimal contact experience and superior seal. The compact design
comfortably fits 98% of patients, providing an open field of vision for a
feeling of greater independence. In patient evaluation trials, seven out of 10
patients found that the Wisp fit better and was more comfortable than their
existing nasal mask.
"I have tried numerous masks in the last 15 years and this is by far the best
for me," said Larry Hanson, patient, age 71. "It is light, fits fantastically,
and I love the small hose which disconnects quickly and easily - perfect for
travel. I now have a much better quality of sleep, only waking up once or
twice. It has changed my life a lot."
The BiPAP autoSV Advanced System One for complex sleep-disordered breathing
patients will also be on display at ERS, featuring clinically-validated
technology such as servo-ventilation (SV) algorithm, unique auto-EPAP and
automatic backup rate functionalities.
New patient benefits of the BiPAP autoSV include a heated tube humidifier,
which provides extra comfort for patients sleeping in a cold environment,
those with pre-existing nasal conditions, or those using sinus drying
"Thanks to servo-ventilation, we managed to stabilize ventilation, resolving
central and obstructive apnea, night hypoxemia and improving hemodynamics in a
patient with congestive heart failure," said Dr. M. Brunori of Policlinico
Umberto and University of Rome.
Improved solutions for better management of chronic respiratory diseases
According to the World Health Organization (WHO), chronic respiratory
diseases, including the deadly condition COPD, account for more than 250
deaths each hour worldwide. To offer better management for these diseases,
Philips is introducing a series of solutions with enhanced features, including
CoughAssist E70, Trilogy ventilator series with mouthpiece ventilation (MPV),
and SimplyGo portable oxygen concentrator (POC).
CoughAssist E70 clears secretions from the lungs by gradually applying
positive air pressure (insufflation) to the airway and then rapidly shifting
to negative air pressure (exsufflation). This in-exsufflation shift in
pressure creates a high expiratory flow that simulates a deep, natural cough.
The CoughAssist E70 incorporates several innovations and features like
Cough-Trak, oscillations, and flow waveforms that improve comfort and aid in
the efficacy of the therapy.
The Trilogy ventilators are designed for use at home, hospital and alternative
care sites, providing invasive and noninvasive ventilatory support for adult
and pediatric patients. The mouthpiece ventilation (MVP) support system
enables on-demand ventilation without the need for an exhalation device.
"MPV technology is the beginningof a paradigm shift in how ventilatory
support will be provided, noninvasively rather than invasively," said Dr. John
Additionally, the light-weight SimplyGo portable oxygen concentrator (POC)
delivers simplified care by providing continuous flow and pulse dose oxygen
therapy to fit most oxygen patients' needs in the treatment of COPD.
In 2013, Mark Junge a 70-year-old US adventurer, cyclist and health advocate
with COPD, embarked on a 500-mile bicycle tour through Canada with the
SimplyGo POC strapped to the back of his bike to help him breathe more easily.
"Thanks to SimplyGo, I was able to use it at a pulse dose while riding, and
set it to a continuous flow of oxygen while biking uphill and sleeping," said
Mark Junge. "It helped me enormously in completing my adventure, and it shows
to the world that people with respiratory problems, such as COPD, are also
capable of fulfilling their lives and achieving ambitions if they can be
Visit Philips Respironics at booth F20 at the 2013 European Respiratory
Society Annual Congress, 7 - 11 September at Fira de Barcelona. On Tuesday, 10
^ September from 13:15 to 14:30, Philips Respironics will host a workshop,
"Avoiding tracheostomies for patients with chronic respiratory insufficiency"
with Dr John R. Bach and Dr Miguel Gonçalves in Room 3.10. For more
information please visit http://www.philips.com/ers2013 .
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful innovation in
the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the
Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs
approximately 115,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and home
healthcare, energy efficient lighting solutions and new lighting applications,
as well as male shaving and grooming and oral healthcare. News from Philips is
located at http://www.philips.com/newscenter .
Contact: For further information, please contact: Joost Maltha, Philips
Healthcare, Tel: +31-6-10-55-8116, E-mail: email@example.com ; Alicia
Cafardi, Philips Healthcare, Tel: +1-724-387-4439, E-mail:
Press spacebar to pause and continue. Press esc to stop.